Osaic Holdings’s Tango Therapeutics TNGX Stock Holding History

Osaic Holdings’s Portfolio TNGX Stock Details TNGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.69K	Sell	182 -243	-57%	-$6.01K	﹤0.01%	6866
2026 Q1	$8.89K	Sell	425 -267	-39%	-$3.72K	﹤0.01%	6372
2025 Q4	$6.13K	Buy	692 +101	+17%	+$870	﹤0.01%	6584
2025 Q3	$4.99K	Buy	591 +91	+18%	+$616	﹤0.01%	6745
2025 Q2	$2.56K	Buy	+500	New	+$1.24K	﹤0.01%	6847
2025 Q1	–	Sell	-330	Closed	-$1.02K	–	7705
2024 Q4	$1.02K	Sell	330 -371	-53%	-$1.72K	﹤0.01%	6841
2024 Q3	$5.4K	Sell	701 -1,745	-71%	-$16.7K	﹤0.01%	6154
2024 Q2	$21K	Buy	+2,446	New	+$18.9K	﹤0.01%	5313

Other funds holding TNGX

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Osaic Holdings's TNGX Position: Q2 2026 in Review

Osaic Holdings reduced its Tango Therapeutics (TNGX) stake by 57% in Q2 2026, selling an estimated $6.01K and leaving 182 shares worth $5.69K. The position accounts for ﹤0.01% of the portfolio, ranked #6866.

Osaic Holdings first reported a position in TNGX in Q2 2024 and has held it in 8 quarters since. The position peaked at $21K in Q2 2024. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

Osaic Holdings held 182 shares of Tango Therapeutics worth $5.69K as of Q2 2026.
Osaic Holdings sold 243 Tango Therapeutics shares in Q2 2026, an estimated $6.01K.
Tango Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6866 holding.
Osaic Holdings first reported a position in Tango Therapeutics in Q2 2024 and has held it in 8 quarters since.
Osaic Holdings's Tango Therapeutics position peaked at $21K in Q2 2024.
248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.